SARS-CoV-2-Specific T Lymphocytes Analysis in mRNA-Vaccinated Patients with B-Cell Lymphoid Malignancies on Active Treatment
mRNA vaccines induced significant humoral and cellular immune responses in B-cell lymphoid malignancy patients, although responses varied by treatment type and malignancy. Further research is needed to optimize vaccination strategies in this population.
Authors
- Miguel Á. Ortega (ORCID: https://orcid.org/0000-0003-2588-1708)
- Julio García‐Suárez (ORCID: https://orcid.org/0000-0001-6294-2544)
- Jorge Monserrat (ORCID: https://orcid.org/0000-0003-1775-4645)
- Melchor Álvarez‐Mon (ORCID: https://orcid.org/0000-0003-1309-7510)
- Marta Callejas Charavía
- Patricia García Ramírez (ORCID: https://orcid.org/0000-0003-1471-5018)
- Ana María Gómez La Hoz
- Raquel Oliva Martin
Institutions
- Universidad de Alcalá (ES)
- Hospital Universitario Príncipe de Asturias (ES)
- Instituto Ramón y Cajal de Investigación Sanitaria (ES)
Publication Details
- Journal
- Vaccines
- Published
- 2024-08-26
- DOI
- https://doi.org/10.3390/vaccines12090961
- Citations
- 1
- Primary Topic
- SARS-CoV-2 and COVID-19 Research
- Type
- article
- Field-Weighted Citation Impact
- 0.39